Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Amgen Inc (AMGN)

Amgen Inc (AMGN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 120,025,728
  • Shares Outstanding, K 589,807
  • Annual Sales, $ 23,362 M
  • Annual Income, $ 7,842 M
  • 60-Month Beta 1.12
  • Price/Sales 5.42
  • Price/Cash Flow 11.35
  • Price/Book 12.92

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 22 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/20
See More
  • Average Estimate 3.72
  • Number of Estimates 10
  • High Estimate 4.08
  • Low Estimate 3.44
  • Prior Year 3.56
  • Growth Rate Est. (year over year) +4.49%

Price Performance

See More
Period Period Low Period High Performance
1-Month
195.29 +1.46%
on 02/28/20
234.64 -15.56%
on 02/05/20
-26.70 (-11.88%)
since 01/28/20
3-Month
195.29 +1.46%
on 02/28/20
244.99 -19.12%
on 12/17/19
-36.40 (-15.52%)
since 11/27/19
52-Week
166.30 +19.15%
on 05/15/19
244.99 -19.12%
on 12/17/19
+8.06 (+4.24%)
since 02/28/19

Most Recent Stories

More News
Esperion (ESPR) Q4 Earnings and Revenues Beat Estimates

Esperion Therapeutics (ESPR) reports encouraging fourth-quarter results. The company is set to launch its first drug next month.

SNY : 45.78 (-4.94%)
MRK : 75.48 (-3.33%)
AMGN : 197.56 (-2.92%)
ESPR : 50.07 (-4.26%)
Karyopharm Appoints Richard Paulson to its Board of Directors

Karyopharm Therapeutics Inc. (Nasdaq:KPTI), an oncology-focused pharmaceutical company, today announced the appointment of Richard Paulson to its Board of Directors. Mr. Paulson is currently Executive...

AMGN : 197.56 (-2.92%)
KPTI : 14.98 (-2.60%)
Amgen To Present At The Cowen 40th Annual Healthcare Conference

Amgen (NASDAQ:AMGN) will present at the Cowen 40th Annual Healthcare Conference at 11:20 a.m. ET on Monday, March 2, 2020 in Boston. Peter H. Griffith, executive vice president and chief financial officer,...

AMGN : 197.56 (-2.92%)
Relatively Good Performance Detected in Shares of Gilead Sciences in the Biotechnology Industry (GILD , REGN , AMGN , BIIB , VRTX )

Here are the top 5 stocks in the Biotechnology industry ranked by performance. We compiled the trading activity from yesterday and then analyzed the industry looking for stocks that were outperforming....

AMGN : 197.56 (-2.92%)
GILD : 68.63 (-5.55%)
REGN : 432.03 (+0.10%)
3 Top Dividend Stocks to Maximize Your Retirement Income - February 26, 2020

The traditional approaches to retirement planning are longer covering all expenses in nest egg years. So what can retirees do? Thankfully, there are alternative investments that provide steady, higher-rate...

AMGN : 197.56 (-2.92%)
DRI : 97.14 (-2.23%)
CVS : 58.00 (-2.24%)
Amgen, Cytokinetics And Servier Announce Continuation Of GALACTIC-HF Following Planned Interim Analysis

Amgen (NASDAQ:AMGN), Cytokinetics, Incorporated (NASDAQ:CYTK) and Servier today announced that the Data Monitoring Committee (DMC) for GALACTIC-HF recently completed the second and final planned interim...

AMGN : 197.56 (-2.92%)
CYTK : 14.21 (+1.94%)
Watch for Amgen Inc to Potentially Rebound After Falling 1.83% Yesterday

Amgen Inc (NASDAQ:AMGN) traded in a range yesterday that spanned from a low of $213.54 to a high of $219.56. Yesterday, the shares fell 1.8%, which took the trading range below the 3-day low of $218.51...

AMGN : 197.56 (-2.92%)
Worldwide Bispecific Antibody Therapeutics Market (2019 to 2030) - Featuring AbbVie, Affibody, Affimed and Amgen Among Others - ResearchAndMarkets.com

The "Bispecific Antibody Therapeutics Market (4th Edition), 2019-2030" report has been added to ResearchAndMarkets.com's offering.

AMGN : 197.56 (-2.92%)
Guardant Health (GH) to Report Q4 Earnings: What's in Store?

During Guardant Health's (GH) Q4 earnings call, investors' focus will be on the updates related to Guardant360 test and the colorectal cancer screening rates of its LUNAR-2 blood test.

AMGN : 197.56 (-2.92%)
SAGE : 47.85 (-8.00%)
CLVS : 7.20 (+5.26%)
GH : 78.96 (+2.33%)
What's in the Cards for Amarin (AMRN) This Earnings Season?

Amarin's (AMRN) fourth-quarter results are likely to reflect strong demand for its cardiovascular drug, Vascepa.

SNY : 45.78 (-4.94%)
AMAG : 7.33 (-2.79%)
AMGN : 197.56 (-2.92%)
AMRN : 14.24 (-2.93%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Sell with a Strengthening short term outlook on maintaining the current direction.

The market is in highly oversold territory. Beware of a trend reversal.

See More Share

Trade AMGN with:

Business Summary

Amgen Inc. discovers, develops and delivers innovative human therapeutics. A biotechnology pioneer, Amgen was one of the first companies to realize the new science's promise by bringing safe and effective medicines from lab, to manufacturing plant, to patient. Amgen therapeutics have changed the practice...

See More

Key Turning Points

2nd Resistance Point 219.39
1st Resistance Point 211.45
Last Price 197.32
1st Support Level 199.39
2nd Support Level 195.27

See More

52-Week High 244.99
Fibonacci 61.8% 214.93
Fibonacci 50% 205.65
Last Price 197.32
Fibonacci 38.2% 196.36
52-Week Low 166.30

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar